Management of dyslipidemia in HIV-infected patients

Abstract

Antiretroviral therapy has dramatically increased survival for HIV-infected individuals. Asthis population lives longer,coronary heart disease has become an important comorbid condition.Dyslipidemia in HIV-infected individuals is a complex condition, with multiple contributing factors including the HIV virus itself, individual genetic characteristics and antiretroviral therapy-induced metabolic changes. Effective management of dyslipidemia in this population is essential to reduce cardiovascular risk but presents multiple challenges due to interactions between antiretroviral therapy agents and lipid-lowering medications.

Keywords:

• drug interactions
• fibrates
• fish oil n guidelines
• HIV-associated
• dyslipidemia
• hypertriglyceridemia
• niacin n statins